Hinge Health, Inc. (HNGE) SEC Filings & Earnings Calls

Long-term lease obligation of $86M increases fixed costs.

“Aggregate estimated base rent payments of approximately $86.0 million.”

History of net losses and increasing expenses

“We have a history of net losses, we anticipate increasing expenses in the future, and we may not be able to achieve or maintain profitability.” · word for word

Dependence on limited number of health plan partners

“A substantial portion of our client relationships are contracted through a limited number of health plans and other partners.” · word for word

Regulatory and compliance risks in healthcare

“Our business operates in a highly regulated industry and changes over time in regulations, or the implementation of existing regulations, could affect our operations and subject us to increased compliance costs and liabilities.” · word for word

Acquisition integration risk; Cylinder Health acquisition for $105M may face execution challenges.

“Signed definitive agreement to acquire Cylinder Health for $105M in cash.”

Stock-based compensation remains significant; GAAP operating income benefited from lower SBC vs prior year.

“Prior year GAAP loss from operations included $591M in stock-based compensation.”

Execution risk on raised guidance; competition in digital health.

“Forward-looking statements caution about risks.”

Share repurchase reduces cash

“Repurchase and retirement of common stock $(104,966) (2026) vs $0 (2025)”

Concentration of client relationships through partners

“A substantial portion of our client relationships are contracted through a limited number of health plans and other partners. If we are unable to establish, maintain, or grow these relationships over time or if the partners refer business to our competitors instead, we are likely to lose a portion of our clients, which could have a material adverse effect on” · word for word

Dependence on non-GAAP metrics; GAAP reconciliation not fully provided for guidance.

“We have not reconciled our non-GAAP income from operations guidance to GAAP income from operations due to uncertainty of stock-based compensation.” · word for word

History of losses and uncertain profitability

“We have a history of net losses, we anticipate increasing expenses in the future, and we may not be able to maintain profitability.” · word for word

Dependence on partner relationships

“A substantial portion of our client relationships are contracted through a limited number of health plans and other partners.” · word for word

AI regulatory uncertainty

“Our increasing reliance on AI and machine learning technologies may expose us to significant risks, including development and deployment challenges, regulatory uncertainties.” · word for word

GAAP loss from operations of $546.4M in FY2025 due to stock-based compensation and other non-cash charges, but non-GAAP profitability is strong.

“GAAP loss from operations was $546.4 million compared to GAAP loss from operations of $31.9 million in 2024.” · word for word

Guidance implies deceleration in revenue growth from 51% in FY2025 to 25% in FY2026, though still strong.

“Full Year 2026: revenue between $732 million and $742 million, reflecting year over year growth of 25% at the midpoint.”

Share repurchase may reduce liquidity if not managed carefully.

“fund repurchases with existing cash and cash equivalents and ongoing cash from operations” · word for word

History of net losses and increasing expenses

“We have a history of net losses, we anticipate increasing expenses in the future, and we may not be able to achieve or maintain profitability.” · word for word

Dependence on limited number of health plan partners

“A substantial portion of our client relationships are contracted through a limited number of health plans and other partners.” · word for word

Regulatory and FDA compliance risk for Enso device

“Our Enso device is subject to extensive government regulation.” · word for word

Rapid growth may strain operations; GAAP loss from operations still negative

“GAAP loss from operations $6.1M vs $3.9M in Q3 2024”